Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.048
Neutral
RSI(14)
55.358
Neutral
STOCH(KDJ)(9,3,3)
56.990
Neutral
ATR(14)
0.131
High Vlolatility
CCI(14)
84.737
Neutral
Williams %R
29.268
Buy
TRIX(12,20)
0.089
Sell
StochRSI(14)
100.000
Buy
Biote Corp
BTMD2.780USD
+0.030+1.09%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
85.29MMarket Cap
3.07P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Biote Corp
Currency: USD Updated: 2025-12-19Key Insights
Biote Corp's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 83/156 in the Professional & Commercial Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.09.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Biote Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
5
analysts
Buy
Current Rating
5.093
Target Price
+98.96%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Biote Corp Highlights
StrengthsRisks
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 19.54% year-on-year.
Fairly Valued
The company’s latest PE is 3.07, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 20.37M shares, decreasing 0.13% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 2.54K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.51.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of Biote Corp is 7.06, ranking 95/156 in the Professional & Commercial Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 47.96M, representing a year-over-year decrease of 6.67%, while its net profit experienced a year-over-year decrease of 23.49%.
Score
Financials
7.46
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.45
Operational Efficiency
8.41
Growth Potential
4.88
Shareholder Returns
7.11
Biote Corp's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of Biote Corp is 5.92, ranking 118/156 in the Professional & Commercial Services industry. Its current P/E ratio is 3.07, which is 6635.12% below the recent high of 206.76 and 1633.48% above the recent low of -47.08.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 83/156
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19The current earnings forecast score of Biote Corp is 8.00, ranking 31/156 in the Professional & Commercial Services industry. The average price target for Biote Corp is 5.03, with a high of 8.00 and a low of 3.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
5.093
Target Price
+98.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
16
Total
9
Median
12
Average
Company name
Ratings
Analysts
Biote Corp
BTMD
5
S&P Global Inc
SPGI
28
Equifax Inc
EFX
26
Moody's Corp
MCO
26
TransUnion
TRU
22
MSCI Inc
MSCI
20
1
2
3
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of Biote Corp is 6.99, ranking 105/156 in the Professional & Commercial Services industry. Currently, the stock price is trading between the resistance level at 2.99 and the support level at 2.47, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
2.694
Buy
MA10
2.705
Buy
MA20
2.643
Buy
MA50
2.716
Buy
MA100
2.974
Sell
MA200
3.396
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of Biote Corp is 7.00, ranking 76/156 in the Professional & Commercial Services industry. The latest institutional shareholding proportion is 73.91%, representing a quarter-over-quarter increase of 2.95%. The largest institutional shareholder is The Vanguard, holding a total of 1.43M shares, representing 4.42% of shares outstanding, with 3.57% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Roystone Capital Management LP
325 Capital LLC
Heyer (Andrew R)
Bandera Partners LLC
BlackRock Institutional Trust Company, N.A.
Heyer (Steven J)
Acadian Asset Management LLC
Geode Capital Management, L.L.C.
Dimensional Fund Advisors, L.P.
1
2
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of Biote Corp is 3.52, ranking 112/156 in the Professional & Commercial Services industry. The company's beta value is 1.14. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.14
VaR
--
240-Day Maximum Drawdown
+60.82%
240-Day Volatility
+69.54%
Return
Best Daily Return
60 days
+9.17%
120 days
+9.17%
5 years
--
Worst Daily Return
60 days
-9.23%
120 days
-24.35%
5 years
--
Sharpe Ratio
60 days
-0.26
120 days
-0.89
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+60.82%
3 years
+71.41%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.89
3 years
-0.20
5 years
--
Skewness
240 days
-0.66
3 years
-0.29
5 years
--
Volatility
Realised Volatility
240 days
+69.54%
5 years
--
Standardised True Range
240 days
+7.99%
5 years
--
Downside Risk-Adjusted Return
120 days
-100.18%
240 days
-100.18%
Maximum Daily Upside Volatility
60 days
+40.14%
Maximum Daily Downside Volatility
60 days
+37.79%
Liquidity
Average Turnover Rate
60 days
+0.49%
120 days
+0.60%
5 years
--
Turnover Deviation
20 days
+50.95%
60 days
+1.81%
120 days
+22.71%
Peer Comparison
Professional & Commercial Services
Biote Corp
BTMD
6.70 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Maximus Inc
MMS
8.82 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
McGrath RentCorp
MGRC
8.73 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
S&P Global Inc
SPGI
8.66 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brady Corp
BRC
8.66 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ennis Inc
EBF
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Biote Corp?
The TradingKey Stock Score provides a comprehensive assessment of Biote Corp based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Biote Corp’s performance and outlook.
How do we generate the financial health score of Biote Corp?
To generate the financial health score of Biote Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Biote Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Biote Corp.
How do we generate the company valuation score of Biote Corp?
To generate the company valuation score of Biote Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Biote Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Biote Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Biote Corp.
How do we generate the earnings forecast score of Biote Corp?
To calculate the earnings forecast score of Biote Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Biote Corp’s future.
How do we generate the price momentum score of Biote Corp?
When generating the price momentum score for Biote Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Biote Corp’s prices. A higher score indicates a more stable short-term price trend for Biote Corp.
How do we generate the institutional confidence score of Biote Corp?
To generate the institutional confidence score of Biote Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Biote Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Biote Corp.
How do we generate the risk management score of Biote Corp?
To assess the risk management score of Biote Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Biote Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Biote Corp.
